Expertise in
3
conditions

Sheng-wei W. Pan

Taipei, TNQ, TW 
Expertise in
3
conditions
Taipei, TNQ, TW 

Overview

Sheng-wei Pan practices practicing medicine in Taipei, Taiwan.

Pan is highly rated in 3 conditions, according to our data. Their clinical expertise encompasses Nontuberculous Mycobacterial Lung Disease, Mycobacterium Avium Complex Infections, Pulmonary Tuberculosis, and Pneumonia.

They are actively involved in clinical research, co-authoring 77 peer reviewed articles and participating in 1 clinical trial.

Locations

Taipei, TNQ, Taiwan
Other Locations
TPQ, Taiwan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

Evaluation of the Efficacy and Safety of a Short-course, Daily, 4-month Regimen Including Isoniazid, Pyrazinamide, Rifapentine and Moxifloxacin (2HZPM/2HPM) for the Treatment of Drug-susceptible Pulmonary Tuberculosis in Taiwan (ESCAPE-TB)
Evaluation of the Efficacy and Safety of a Short-course, Daily, 4-month Regimen Including Isoniazid, Pyrazinamide, Rifapentine and Moxifloxacin (2HZPM/2HPM) for the Treatment of Drug-susceptible Pulmonary Tuberculosis in Taiwan (ESCAPE-TB)
Enrollment Status: Unknown
Publish Date: July 12, 2024
Intervention Type: Drug
Study Drug: 4-Month Rifapentine-Based Regimen
Study Phase: Phase 3

77 Total Publications

Inhaled 3% hypertonic saline is associated with improved symptoms and microbiological stabilisation in antibiotic-naïve nontuberculous mycobacterial lung disease: A prospective study.
Inhaled 3% hypertonic saline is associated with improved symptoms and microbiological stabilisation in antibiotic-naïve nontuberculous mycobacterial lung disease: A prospective study.
Journal: Pulmonology
Published: July 20, 2026

Frequently Asked Questions about Sheng-wei W. Pan

Is Sheng-wei W. Pan a top-rated expert for Nontuberculous Mycobacterial Lung Disease?

MediFind is an objective health platform that identifies experts based on real-world data. Sheng-wei W. Pan is classified as an Elite expert for Nontuberculous Mycobacterial Lung Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Sheng-wei W. Pan participate in research or clinical trials?

Yes. Sheng-wei W. Pan has published 77 articles and abstracts on conditions like Nontuberculous Mycobacterial Lung Disease. You can view a list of Sheng-wei W. Pan's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Pan's expertise for a condition
ConditionClose
View All 12 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile